The fall and rise of chloramphenicol

Journal of AAPOS

Volumn 7, Issue 5, 2003, Pages 307-308

  Isenberg, Sherwin J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CORTICOSTEROID; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PHENOTHIAZINE DERIVATIVE; POLYMYXIN;

ANAMNESIS; ANAPHYLAXIS; ANTIBACTERIAL ACTIVITY; APLASTIC ANEMIA; BLOOD DYSCRASIA; CONJUNCTIVITIS; DRUG ADSORPTION; DRUG COST; DRUG EFFICACY; DRUG UTILIZATION; EDITORIAL; ERYTHROID CELL; EYE INFECTION; FATALITY; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0141923671     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-8531(03)00169-1     Document Type: Editorial

References (12)

1. Fraunfelder F.T., Bagby G.C., Kelly D.J. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol. 93:1982;356-360.
2. Fraunfelder F.T., Morgan R.L., Yunis A.A. Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol. 115:1993;812-813.
3. Trope G.E., Lawrence J.R., Hind V.M.D., Bunney J. Systemic absorption of topically applied chloramphenicol eyedrops. Br J Ophthalmol. 63:1979;690-691.
4. Mulla R.J., Barnes R., Rogers T.R. Is it time to stop using chloramphenicol on the eye? Fear based on only six cases. Br Med J. 311:1995;450.
5. McGhee C.N., Anastas C.N. Widespread ocular use of topical chloramphenicol is there justifiable concern regarding idiosyncratic aplastic anaemia? Br J Ophthalmol. 80:1996;182-184.
6. Laporte J.R., Vidal X., Ballarin E., Ibanez L. Possible association between ocular chloramphenicol and aplastic anemia - the absolute risk is very low. Br J Clin Pharmacol. 46:1998;181-184.
7. Bron A.J., Leber G., Rizk S.N., Baig H., Elkington A.R., Kirkby G.R., et al. Ofloxacin compared with chloramphenicol in the management of external ocular infections. Br J Ophthalmol. 75:1991;675-679.
8. Miller I.M., Wittreich J.M., Cook T., Vogel R. The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. Eye. 6:1992;111-114.
9. van Renburg S.F.J., Gibson J.R., Harvey S.G., Burke C.A. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis. Pharmatherapeutica. 3:1982;274-277.
10. Jauch A., Fsadni M., Gamba G. Meta-analysis of six clinical phase iii studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefe's Arch Clin Exp Ophthalmol. 237:1999;705-713.
11. Red Book. Montvale (NJ): Thompson Medical Economics; 2002. p. 265.
12. Rayner S.A., Buckley R.J. Ocular chloramphenicol and aplastic anemia. Is there a link? Drug Saf. 14:1996;273-276.